Sort
82,697 grants matching “vaccine development”
Collaborative Research: Ideas Lab: The Role of Extracellular RNA in Intercellular and Interkingdom Communication
$796,460Glen M Borchert · University Of South Alabama · · FY2023 · BIO
Universal T cell targeted influenza vaccine
$796,383Daniel F. Hoft · Saint Louis University · R01 · FY2020 · AI
Post-exposure immunotherapy for ricin exposure
$796,370Miles Burke Brennan · Zabbio, Inc. · R44 · FY2020 · AI
DNA Vaccine for Seasonal & Pandemic Influenza
$796,340Deborah L. Fuller · Albany Medical College · U01 · FY2007 · AI
Production and purification of biological compounds
$796,269Joseph Shiloach · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIC · FY2017 · DK
Immunogen Design Strategies To Direct Hiv-1 Broadly Neutralizing Antibody Maturation By Probability-Based Targeting Of Critical Mutations
$796,260Kevin Wiehe · Duke University · R56 · FY2019 · AI
Viral priming and targeting NK cells against solid tumor malignancies
$796,220Jeffrey S Miller · University Of Minnesota · R35 · FY2018 · CA
Structure And Assembly Of The Hepatitis B Nucleocapsid Protein
$796,218Paul T Wingfield · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2013 · AR
Preclinical Development of Ad26/Env Vaccines for HIV
$796,214Dan H. Barouch · Beth Israel Deaconess Medical Center · U19 · FY2019 · AI
Preclinical Development of Ad26/Env Vaccines for HIV
$796,214Dan H. Barouch · Beth Israel Deaconess Medical Center · U19 · FY2020 · AI
Identification and analysis of compensatory mutations that support the evolution of antibiotic resistance in Neisseria gonorrhoeae
$796,194Yonatan H Grad · Harvard School Of Public Health · R01 · FY2020 · AI
Anti-norovirus protease inhibitors for immunocompromised patients
$796,178Raymond F. Schinazi · Emory University · R01 · FY2023 · AI
A vaccine for genital herpes that achieves sterilizing immunity
$796,177Harvey Michael Friedman · University Of Pennsylvania · R01 · FY2020 · AI
HIV-Receptor Interactions and Related Anti-HIV Strategies
$796,158Edward Berger · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI
High-resolution definition of B cell responses to HIV Env for immunogen design
$796,104Yuxing Li · University Of Maryland Baltimore · R01 · FY2021 · AI
High-resolution definition of B cell responses to HIV Env for immunogen design
$796,104Yuxing Li · University Of Maryland Baltimore · R01 · FY2022 · AI
High-resolution definition of B cell responses to HIV Env for immunogen design
$796,104Yuxing Li · University Of Maryland Baltimore · R01 · FY2020 · AI
Structure-based design of coronavirus subunit vaccines
$796,048Lanying Du · Georgia State University · R01 · FY2022 · AI
Immune responses defining efficiency of influenza vaccination
$796,005Albert C Shaw · Yale University · U19 · FY2012 · AI
Understanding Unconventional CD8+ T cell Responses in Protection from HIV
$795,947Jonah B. Sacha · Oregon Health & Science University · R01 · FY2023 · AI
New Algorithms and Software for Mass Spectrometric Analysis of Intact Proteins and Complexes
$795,816Marshall Wayne Bern · Protein Metrics, Llc · R44 · FY2022 · GM
Dramatic CD4+ T cell depletion without simian AIDS in SIV+ mangabeys
$795,770Donald L Sodora · Seattle Biomedical Research Institute · R56 · FY2010 · AI
Vaccines and Therapeutics for Anthrax
$795,740Stephen Leppla · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI
Synthesis of Antitumor Natural Products
$795,705Samuel J Danishefsky · Sloan-Kettering Inst Can Research · R37 · FY2010 · CA
Immunology of Acute and Chronic Viral Hepatitis
$795,677Barbara Rehermann · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2016 · DK